Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725137 | SCV000334359 | uncertain significance | not provided | 2015-08-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001085712 | SCV000638704 | benign | Generalized epilepsy-paroxysmal dyskinesia syndrome | 2024-12-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725137 | SCV001790301 | likely benign | not provided | 2020-05-04 | criteria provided, single submitter | clinical testing | In silico analysis, which includes splice predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Genetic Services Laboratory, |
RCV000117323 | SCV000151504 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Prevention |
RCV004549583 | SCV004744277 | likely benign | KCNMA1-related disorder | 2024-06-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |